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Study question: Are perinatal outcomes different between singleton live births conceived from 22 
fresh blastocyst transfer than those following the transfer of fresh cleavage-stage embryos? 23 
Summary answer: Fresh blastocyst transfer does not increase risks of preterm birth, low/high 24 
birth weight and congenital anomaly, alter the sex ratio at birth or prejudice the chance of  a 25 
having a healthy baby. 26 
What is known already: Extended embryo culture is currently considered the best option for 27 
embryo selection, but concerns have been raised about increased risks of preterm delivery and 28 
large for gestational age (LGA) babies.  29 
Study design, size, duration: We conducted a retrospective cohort study based on data from 30 
the Human Fertilisation and Embryology Authority (HFEA) anonymised and cycle-based 31 
dataset in the United Kingdom (UK) between 1999 and 2011.  32 
Participants/materials, setting, methods: Baseline characteristics were compared between 33 
blastocyst-stage and cleavage-stage embryo transfer cycles using the Chi-squared test for 34 
categorical/dichotomised covariates and the Mann-Whitney test for continuous covariates. 35 
Statistical significance was set at < 0.005. Poisson regression and multinomial logistic 36 
regression were used to establish relationships between perinatal outcomes and blastocyst-37 
stage embryo transfer or cleavage-stage embryo transfer. Risk ratios (RRs), adjusted risk ratios 38 
(aRRs) and their 99.5% confidence intervals (CIs) were calculated as a measure of strength of 39 
associations. Results were adjusted for clinically relevant covariates. A sub-group analysis 40 
included women undergoing their first IVF/ICSI treatment. Level of significance was set at < 41 
0.05 and 95% CIs were calculated in the sub-group analysis.   42 
Main results and the role of chance: Of a total of 67,147 IVF/ICSI cycles, 11,152 involved 43 
blastocyst-stage embryo(s) and 55,995 involved cleavage-stage embryo(s). The two groups 44 
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were comparable with regards to the risk of preterm birth (aRR 1.00, 99.5% confidence interval 45 
[CI] 0.79-1.25), very preterm birth (aRR 1.00, 99.5% CI 0.63-1.54), very low birth weight 46 
(aRR 0.84, 99.5% CI 0.53-1.34), low birth weight (aRR 0.92, 99.5% CI 0.73-1.16), high birth 47 
weight (aRR 0.94, 99.5% CI 0.75-1.18) and very high birth weight (aRR 1.05, 99.5% CI 0.66-48 
1.65). The risk of congenital anomaly was 16% higher in the blastocyst-stage group than in the 49 
cleavage-stage group but this was not statistically significant (aRR 1.16, 99.5% CI 0.90-1.49). 50 
The chance of having a healthy baby (born at term, with normal birth weight and no congenital 51 
anomalies) was not altered by extended culture (aRR 1.00, 99.5% CI 0.93-1.07). Extended 52 
culture was associated with a marginal increase in the chance having a male baby in the main 53 
cycle-based analysis (aRR 1.04, 99.5% CI 1.01-1.09), but not in the sub-group analysis of 54 
women undergoing their first cycle of treatment (aRR 1.04, 95% CI 1.00-1.08). In the sub-55 
group analysis, the risk of congenital anomalies was significantly higher after blastocyst-stage 56 
embryo-transfer (aRR 1.42, 95% CI 1.12-1.81).  57 
Limitations, reasons for caution: This study is limited by the use of observational data and 58 
inability to adjust for key confounders, such as maternal smoking status and body mass index 59 
(BMI) which were not recorded in the HFEA dataset. As the main analysis was cycle based 60 
and unable to link cycles within women undergoing more than one IVF/ICSI cycle, we 61 
undertook a subgroup analysis on women undergoing their first treatment cycle. 62 
Wider implications of the findings: Our findings should reassure women undergoing 63 
blastocyst-stage embryo transfer. For the first time, we have shown that babies born after 64 
blastocyst transfer have a similar chance of being healthy as those born after cleavage-stage 65 
embryos transfer.  66 
4 
 
Study funding/competing interest(s): Research activity of Dr. Nicola Marconi was funded 67 
by Fondo “A. Griffini-J. Miglierina”, Provincia di Varese, Italy. All the authors do not have 68 
any competing interests to disclose.  69 
Key words 70 
Blastocyst, cleavage, extended culture, perinatal outcome, singleton live birth. 71 
Introduction 72 
Extended culture leading to embryo transfer at the blastocyst-stage is considered a major 73 
advance in in vitro fertilisation (IVF) as it has been shown to result in higher live birth rates in 74 
comparison to cleavage-stage embryo transfer (Glujovsky et al., 2016). Theoretical advantages 75 
of transferring blastocysts include the ability to select better quality embryos, better embryo-76 
endometrium synchronisation and reduced uterine contractility 5 days after fertilisation 77 
(Maheshwari et al., 2013). Extended culture is therefore perceived as the best option for 78 
selecting embryos for elective single embryo transfer (eSET) by reducing the risk of multiple 79 
pregnancies (Vega et al., 2018), without compromising live birth rates.  80 
Although there are a number of advantages, there are conflicting data on perinatal outcomes of 81 
singleton pregnancies resulting from blastocyst-stage embryo transfer. Some studies are 82 
suggesting a  higher risk of preterm birth (PTB), very preterm birth (VPTB) and large for 83 
gestational age (LGA) babies, after blastocyst-stage embryo transfer as compared to cleavage-84 
stage embryo transfer (Maheshwari et al., 2013; Wang et al., 2017; Alviggi et al., 2018), 85 
whereas others have shown no difference (Litzky et al., 2018; Shi et al., 2019).  86 
The Human Fertilisation and Embryology Authority (HFEA) database of the United Kingdom 87 
(UK) is the oldest and one of the largest registers of ART treatments worldwide. The 88 
anonymised version of the database provides information on every IVF/ICSI cycle performed 89 
in the UK since 1991. The aim of this study was to use anonymised HFEA data to explore 90 
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perinatal outcomes of singleton live births following fresh blastocyst-stage embryo transfer 91 
cycles in comparison to those following fresh cleavage-stage embryo transfer cycles. The use 92 
of the HFEA dataset represents a unique opportunity as it contains information about more than 93 
a million ART cycles performed in all the UK licensed fertility centres. 94 
Materials and methods 95 
We performed a retrospective cohort study using anonymised cycle-based HFEA data recorded 96 
from 1991 to 2012 (https://www.hfea.gov.uk/about-us/our-data/). As these data are freely 97 
available on the HFEA website, no ethical approval was necessary for their use. We selected 98 
all fresh IVF/ICSI cycles that resulted in a singleton live birth after the transfer of either 99 
blastocyst-stage or cleavage-stage embryo(s). Cycles transferring frozen embryos were 100 
excluded as it has been shown that freezing-thawing techniques can affect perinatal outcomes 101 
of IVF/ICSI singleton pregnancies (Maheshwari et al., 2018). Cycles resulting in a multiple 102 
pregnancy were also excluded. We wanted to focus on singleton live births as extended embryo 103 
culture is considered the best option for embryo selection to achieve a singleton pregnancy. In 104 
addition, perinatal outcomes of babies born from twin or higher order gestations are not 105 
independent. Standard analytic approaches have not been established for the purpose of 106 
exploring such outcomes, with risks of low accuracy and precision in the results (Hibbs et al., 107 
2010). Cycles performed before 1999 were excluded due to the extremely low number of 108 
blastocyst-stage transfers; cycles performed in 2012 were excluded due to the lack of updated 109 
reproductive and perinatal information in the dataset. As a consequence, the study focused on 110 
the period 1999-2011. Donor/surrogate, unstimulated and preimplantation genetic testing 111 
(PGT) cycles were excluded. Cycles with contradictory data, relevant to the purpose of cycle 112 
selection, and missing information in outcome measures were also excluded. Cycles included 113 
in the analysis were divided into 2 exposure groups: blastocyst-stage embryo transfer group 114 
and cleavage-stage embryo transfer group.  115 
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Baseline characteristics recorded for each cycle in the anonymised HFEA dataset, such as 116 
maternal age at treatment and duration of infertility, were compared between the blastocyst-117 
stage and the cleavage-stage groups. Perinatal outcomes that were assessed between the groups 118 
were: gestational age at delivery (full-term birth >37 weeks, PTB 32-36 weeks + 6 days and 119 
very preterm birth [VPTB] <32 weeks), birth weight at delivery (very low birth weight 120 
[VLBW] <1,500 g, LBW 1,500 g-2,499 g, normal birth weight [NBW] 2,500 g-3,999 g, high 121 
birth weight [HBW] 4,000 g-4,499 g and very high birth weight [VHBW] >4,500 g), gender of 122 
the baby (male;female), congenital anomaly (yes;no) and healthy baby (yes;no). In addition, 123 
the categories of LBW and VLBW were combined into the category of total low birth weight 124 
(TLBW). Similarly, HBW and VHBW were combined into total high birth weight (THBW). 125 
In the HFEA dataset, congenital anomalies diagnosed at birth were recorded as 1 (yes) and 0 126 
(no) without providing any distinctions among specific anomalies. Healthy babies were defined 127 
as singletons born full-term, with a NBW and no congenital anomalies.  128 
Statistical analysis 129 
Comparison of baseline characteristics between the blastocyst-stage and the cleavage-stage 130 
groups was performed using the Chi-squared test for categorical/dichotomised covariates and 131 
the Mann-Whitney test for continuous covariates. Poisson regression and multinomial logistic 132 
regression were used to establish relationships between binary-multiple categorical outcomes 133 
and blastocyst-stage embryo transfer as compared to cleavage-stage embryo transfer (risk ratios 134 
[RRs]).  135 
The HFEA dataset is anonymised and cycle-based, hence linkage of cycles within each woman 136 
undergoing IVF/ICSI treatment was not possible. Inability to adjust for clustering of cycles 137 
within women is likely to lead to spurious associations which are statistically significant. We 138 
therefore opted for 99.5% confidence intervals (CIs) and a level of significance at < 0.005 139 
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(Sunkara et al., 2014; Maheshwari et al., 2016). Clinically relevant confounders that were 140 
statistically different between the groups at p < 0.20 were included in the adjustment models 141 
for each outcome (adjusted risk ratio [aRR], 99.5% CI). Potential confounders were maternal 142 
age at treatment, year of treatment, duration of infertility, previous pregnancy, causes of 143 
infertility, type of fertilisation (IVF/ICSI), number of fresh oocytes collected, number of 144 
embryos transferred and gender of the baby. The assumption of linearity between continuous 145 
covariates and outcomes was evaluated using Box-Tidwell procedure (Box and Tidwell, 1962) 146 
and where assumption was violated, it was decided to include a square or polynomial 147 
component as an adjustment variable into the model. 148 
A sub-group analysis of women undergoing their first IVF/ICSI treatment was performed, with 149 
a p value of less than 0.05 deemed statistically significant. RRs, aRRs and theirs 95% CIs were 150 
calculated using standard methods.    151 
Sensitivity analyses were performed using a multiple imputation (MI) technique for missing 152 
data with the aim to test the robustness of the results obtained with the complete case method 153 
in both the main and the sub-group analysis (Supplementary Table SI). Statistical analyses 154 
were carried out using IBM SPSS Statistics 24.0 (Armonk, NY: IBM Corp.). 155 
Results 156 
The total number of assisted reproductive technology (ART) cycles recorded in the HFEA 157 
dataset from 1991 to 2012 was 1,071,040 (Figure 1). 67,147 IVF/ICSI cycles resulting in a 158 
singleton live birth were included in the main analysis (Figure 1). Of these blastocyst transfers 159 
accounted for 11,152 cycles while cleavage stage transfers occurred in 55,995 cycles (Figure 160 
1). The proportion of blastocyst-stage transfer cycles increased from 1999 to 2011 (p < 0.001) 161 
(Figure 2).  162 
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Table I compares the baseline characteristics in the blastocyst-stage and cleavage-stage embryo 163 
transfer groups. The two differed in terms of cause of infertility (p < 0.001) (with the exception 164 
of endometriosis, p = 0.103), previous pregnancy (p < 0.001), type of fertilisation (p < 0.001), 165 
number of fresh oocytes collected (p < 0.001), number of embryos transferred (p < 0.001), 166 
elective single embryo transfer (p < 0.001) and number of gestational sacs (p < 0.001) (Table 167 
I). The groups did not differ in maternal age at treatment (p = 0.025) and in duration of 168 
infertility (p = 0.864), which was the only covariate with missing data (Table I).  169 
Table II shows comparison of perinatal outcomes between the blastocyst-stage and cleavage-170 
stage groups. The risk of PTB (aRR 1.00, 99.5% CI 0.79-1.25) and VPTB (aRR 1.00, 99.5% 171 
CI 0.63-1.54) was similar in the two groups after adjusting for confounders (Table II). The 172 
risks of VLBW (aRR 0.84, 99.5% CI 0.53-1.34), LBW (aRR 0.92, 99.5% CI 0.73-1.16), HBW 173 
(aRR 0.94, 99.5% CI 0.75-1.18), VHBW (aRR 1.05, 99.5% CI 0.66-1.65), TLBW (aRR 0.90, 174 
99.5% CI 0.73-1.12) and THBW (aRR 0.96, 99.5% CI 0.78-1.18) were no higher following 175 
blastocyst-stage embryo transfer (Table II).  176 
A higher proportion of male babies, with a very low statistical and clinical significance, was 177 
noted following blastocyst-stage embryo transfer (aRR 1.04, 99.5% CI 1.01-1.09) (Table II). 178 
The risk of congenital anomalies was similar in the two groups (aRR 1.16, 99.5% CI 0.90-1.49) 179 
(Table II).  180 
There was no difference in the proportion of healthy babies between blastocyst-stage and 181 
cleavage-stage embryo transfer cycles (aRR 1.00, 99.5% CI 0.93-1.07) (Table II).  182 
Sub-group analysis of women undergoing their first IVF/ICSI cycle 183 
The baseline characteristics of women undergoing their first IVF/ICSI cycle are shown in Table 184 
I. Women who had blastocyst transfer differed from those who had cleavage-stage embryos 185 
replaced in terms of age (p = 0.002), cause of infertility (with the exception of endometriosis, 186 
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p = 0.175), use of IVF versus ICSI (p < 0.001), oocytes collected (p < 0.001), number of 187 
embryos transferred (p < 0.001) and elective single embryo transfer (p < 0.001) (Table I). 188 
Duration of infertility was the only covariate with missing data and the proportion of cycles in 189 
which the couple was trying for > 4 years was significantly higher in the cleavage-stage group 190 
than in the blastocyst-stage group (p < 0.001).  191 
Table III shows comparison of perinatal outcomes between the blastocyst-stage and cleavage-192 
stage groups. There was no significant difference in the risk of PTB (aRR 0.93, 95% CI 0.72-193 
1.21) and VPTB (aRR 1.01, 95% CI 0.61-1.64), VLBW (aRR 1.02, 95% CI 0.64-1.63), LBW 194 
(aRR 0.82, 95% CI 0.63-1.07), HBW (aRR 1.03, 95% CI 0.79-1.34), VHBW (aRR 1.21, 95% 195 
CI 0.69-2.11), TLBW (aRR 0.86, 95% CI 0.68-1.09) and THBW (aRR 1.06, 95% CI 0.83-196 
1.34) after blastocyst-stage embryo-transfer (Table III). The chance of delivering a male baby 197 
was not increased by blastocyst-stage embryo transfer (aRR 1.04, 95% CI 1.00-1.08) (Table 198 
III) but the risk of congenital anomaly was significantly higher (aRR 1.42, 95% CI 1.12-1.81) 199 
(Table III). The chance of the baby being healthy was also similar in the two groups (aRR 0.97, 200 
99.5% CI 0.90-1.05) (Table III). 201 
Results of sensitivity analyses 202 
Results of the sensitivity analysis using MI for missing data were comparable with those from 203 
the CC method for both the main and the sub-group analyses (Table II and Table III) except 204 
for a few outcomes. In the main analysis, the chance of delivering a male baby (aRR 1.04, 205 
99.5% CI 1.00-1.09) was not increased by blastocyst-stage embryo transfer in the MI analysis, 206 
whereas it was slightly increased in the CC analysis. In the sub-group analysis, the risk of LBW 207 
(aRR 0.86, 99.5% CI 0.76-0.98) was significantly lower in blastocyst-stage embryo transfer 208 
cycles in the MI analysis, whereas the difference was not statistically relevant with the CC 209 
method. In women undergoing their first cycle, the risk of congenital anomaly following 210 
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blastocyst transfer (aRR 1.00, 95% CI 0.78-1.26) was no higher in the MI analysis but increased 211 
in analysis using the CC method.  212 
Discussion  213 
Principal findings  214 
In singleton live births conceived through fresh IVF/ICSI in the UK between 1999 and 2011, 215 
the risks of PTB, VPTB, LBW and HBW were not increased following blastocyst-stage embryo 216 
transfer. The chance of delivering a healthy baby was not affected by embryo transfer at 217 
blastocyst-stage.  The results were similar when only first cycles were included.  218 
Strengths 219 
Data were extracted from a nationwide dataset, which collates information on all IVF and ICSI 220 
treatment cycles undertaken in the UK and is subject to thorough and regular checks. Our 221 
analysis adjusted for important covariates recorded in the dataset such as maternal age, duration 222 
of infertility, causes of infertility and year of treatment and included deliveries of singleton 223 
healthy babies as an outcome. 224 
Limitations 225 
An important limitation of our study was the use of cycle-based anonymised data. Cycles 226 
performed in the same women could not be linked to each other. As clustering of cycles within 227 
women can lead to spuriously narrow standard errors (SEs) and CIs, statistical significance was 228 
set at < 0.005 and 99.5% CIs were computed  (Sunkara et al., 2014; Maheshwari et al., 2016). 229 
In addition, we have reported outcomes in women undergoing their first IVF/ICSI treatment as 230 
a sub-group analysis that addressed the issue of cycle clustering more appropriately.  231 
Only cycles performed until 2011 were included in this analysis as only data up to 2012 were 232 
available from the HFEA website in September 2017, when the study commenced. Data from 233 
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the period 2012-2019, which report a larger proportion of blastocyst transfers and reflect other 234 
changes in clinical and laboratory practice (https://www.hfea.gov.uk/about-us/publications/), 235 
have only recently become available and could not be included in our study.  236 
This study was limited by the inability to adjust the results for important covariates such as 237 
smoking status, body mass index (BMI), previous medical history and nature of the embryo 238 
culture medium used as this information was not reported in the dataset. Information regarding 239 
complications of pregnancy (gestational diabetes, hypertensive complications etc.) was also 240 
not recorded. Congenital anomalies diagnosed at delivery were reported in the dataset but the 241 
data did not discriminate between different kinds of anomalies. Information about perinatal 242 
mortality was not available. Maternal age, gestational age at delivery and birth weight were 243 
recorded in bands and parameters such as Z-scores for those outcomes could not be computed. 244 
Therefore, our findings could be affected by residual confounding. 245 
In order to deal with the issue of missing data among covariates (duration of infertility), the 246 
CC method was initially used in both the main and sub-group analyses. One requirement in 247 
order to obtain unbiased estimates with the CC method is that data must be missing completely 248 
at random (MCAR) (i.e. missingness is unrelated to observed and unobserved data yielding a 249 
sub-group of cases with complete data that is representative of the total cohort) (Desai et al., 250 
2011). It was not possible to assess the MCAR assumption in the HFEA dataset and, therefore, 251 
it is likely that cases with complete data were not representative of the larger cohort and might 252 
have produced biased results (Bennett, 2001; Desai et al., 2011; Pedersen et al., 2017). 253 
Therefore, sensitivity analyses for the main dataset as well as the sub-group of women in their 254 
first cycles were performed to test the robustness of their findings which showed similar results  255 
Another limitation was that the analysis of a large number or cycles might have produced 256 
spurious and not clinically relevant associations between outcomes and exposure groups 257 
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(Grimes and Schulz, 2012). This can be seen, for example, in the higher chance of delivering 258 
a male baby after blastocyst-stage embryo transfer (aRR 1.04, 99.5% CI 1.01-1.09) shown in 259 
the main analysis using the CC method. This association was weak and likely produced by the 260 
large number of cycles included in the analysis and by the lack of adjustment for confounders 261 
not recorded in the HFEA dataset such as smoking status and BMI (Grimes and Schulz, 2012). 262 
As a matter of fact, although adjustment for unavailable confounders was still not possible, the 263 
association was not maintained using the MI method in the main analysis and in the sub-group 264 
analysis where the number of cycles was almost halved in comparison to the main analysis.  265 
Comparison with other studies  266 
Three recent register-based studies concurred with our results in reporting no increased risk of 267 
PTB and VPTB in singleton pregnancies following blastocyst-stage embryo transfer as 268 
compared to cleavage-stage embryo transfer (Ishihara et al., 2014; Chambers et al., 2015; 269 
Ginström Ernstad et al., 2016). Another study published in 2019 (Shi et al., 2019), analysing 270 
data of IVF/ICSI cycles performed in a single Chinese centre between January 2006 and 271 
December 2015, did not find any significant differences in the proportions of PTB (aOR 0.99, 272 
95% CI 0.71-1.37) and VPTB (aOR 2.56, 95% CI 0.97-6.78) between singleton pregnancies 273 
after fresh blastocyst-stage and those after fresh cleavage-stage embryo transfer. On the other 274 
hand, three older register-based studies reported a higher risk of PTB and VPTB in singleton 275 
pregnancies following blastocyst-stage embryo transfer as compared to cleavage-stage embryo 276 
transfer (Källén et al., 2010a; Kalra et al., 2012; Dar et al., 2013). However, Kallen et al. 277 
included fresh and frozen-thawed cycles in the analysis without adjusting results for the 278 
proportions of fresh and frozen-thawed embryo transfers (Källén et al., 2010a). Furthermore, 279 
the number of babies born following blastocyst-stage embryo transfer (1,311) was reported to 280 
be too small for the assessment of rare outcomes. The study by Kalra et al. included a larger 281 
number of cases than our study but it was limited to the period 2004-2006, whereas we could 282 
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include cycles performed until 2011 (Kalra et al., 2012). The study by Dar et al. included a 283 
lower number of singleton pregnancies resulting from blastocyst-stage and cleavage-stage 284 
embryo transfer than in our analysis. The same study could not provide a full coverage of 285 
information as only 86% and 95% of Canadian ART clinics reported information in 2001 and 286 
2002 respectively. In addition, the study might be at risk of recall bias as information about 287 
perinatal outcomes was collected by each clinic via telephone or e-mail a posteriori (Dar et al., 288 
2013). Although previous studies have adjusted for several confounders, as in our study, they 289 
were unable to adjust for BMI and smoking status as they were not recorded in the relevant 290 
datasets (Källén et al., 2010a; Kalra et al., 2012; Dar et al., 2013). 291 
A recent Swedish register-based study by Giström Ernstad and colleagues (Ginström Ernstad 292 
et al., 2016) did not show an increased risk of babies weighing > 4,500 g in singleton 293 
pregnancies after blastocyst-stage embryo-transfer as in our study. The same study reported a 294 
lower risk of LBW with extended culture but the association was weak (aOR 0.83, 95% CI 295 
0.71-0.97). This finding is similar to that of our sensitivity sub-group analysis that showed a 296 
lower risk of LBW in singleton live births after extended culture. Furthermore, other studies 297 
showed lower proportions of SGA babies and higher proportions of large for gestational age 298 
(LGA) babies with extended culture as compared to cleavage-stage embryo transfer (Ishihara 299 
et al., 2014; Martins et al., 2016; Wang et al., 2017; Alviggi et al., 2018). These studies 300 
interpreted the increased proportions of LGA babies as a possible explanation for the lower 301 
risks of SGA babies. We could not compare proportions of SGA and LGA babies between the 302 
blastocyst-stage and the cleavage-stage groups as birth weight was recorded in bands in the 303 
anonymised HFEA dataset. A recent American register-based study (Litzky et al., 2018), 304 
including data of fresh IVF/ICSI cycles performed between 2007 and 2014 that resulted in a 305 
singleton live birth, did not show any difference in the rates of macrosomia (RR 1.00, 95% CI 306 
0.96-1.04) and LBW (RR 1.00, 95% CI 0.93-01.06) between the blastocyst-stage and the 307 
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cleavage-stage transfer groups. However, as in our study, they used unlinked data and could 308 
examine repeated cycles in the same women. Only good prognosis cycles resulting in a 309 
pregnancy delivered at term were included. Important covariates such as types of culture media 310 
used and obstetric complications during pregnancy could not be included in adjustment models. 311 
In our main analysis, we found an increase in the proportion of male babies after blastocyst-312 
stage embryo transfer (aRR 1.04, 99.5% CI 1.01-1.09) which was statistically significant but 313 
of minimal clinical significance. This result was not confirmed in the sub-group analysis of 314 
women undergoing an initial IVF/ICSI cycle. The vast majority of previous studies did not 315 
show differences in the proportion of male babies among singletons born as a result of embryo-316 
transfer at blastocyst-stage when compared to cleavage-stage embryo transfer (Wikland et al., 317 
2010; Martin et al., 2012; Oron et al., 2014; De Vos et al., 2015; Maxwell et al., 2015; Li et 318 
al., 2017). A register-based study exploring this outcome (Ginström Ernstad et al., 2016) found 319 
a higher proportion of male babies in singleton pregnancies with extended culture as compared 320 
to cleavage-stage embryo transfer (aOR 1.10, 95% CI 1.03-1.17). A similar result has been 321 
found in the recent single centre study by Shi and colleagues (aOR 1.17, 95% CI 1.07-1.30). 322 
(Shi et al., 2019). However, in both cases, the association was weak as that reported in our 323 
main analysis and likely referable to residual confounding (Ginström Ernstad et al., 2016).   324 
Almost all the previous studies found a similar risk of congenital anomaly between blastocyst-325 
stage and cleavage-stage singletons (Wikland et al., 2010; Martin et al., 2012; Dar et al., 2013; 326 
Oron et al., 2014, 2015; Ginström Ernstad et al., 2016). In our study, the risk of congenital 327 
anomaly was similar between the groups with the exception of the sub-group CC analysis 328 
where the risk was increased in the blastocyst-stage group. However, the number of cycles 329 
included in the sub-group analysis was almost halved in comparison to the main analysis and 330 
cycles with missing data were excluded in the computation of aRRs using the CC method. An 331 
increased risk was no longer observed after imputation of missing data in the sensitivity 332 
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analysis. By contrast, a Swedish register-based study published in 2010 reported a higher risk 333 
of congenital anomaly in singletons following extended culture when compared to singletons 334 
following cleavage-stage embryo transfer (aOR 1.43, 95% CI 1.14-1.81) (Källén et al., 2010b). 335 
However, this study used data from 2002 to 2006, analysed fresh and frozen cycles as a single 336 
group and did not adjust for a number of relevant confounders.  337 
Implications for clinical practice  338 
Our findings provide some reassurance for women undergoing blastocyst transfers at a time 339 
when this strategy is gaining popularity across the world. Extended culture represents an 340 
effective way of maintaining high pregnancy rates with eSET whilst reducing the risk of 341 
multiple pregnancy (Glujovsky et al., 2016). 342 
Implications for research 343 
As with all observational research, we were unable to adjust for unrecorded confounders. An 344 
option to overcome this limitation might be to analyse data on perinatal outcomes in children 345 
conceived through either blastocyst-stage or cleavage-stage embryos from the relevant RCTs 346 
comparing the two strategies of embryo transfer. However, the available RCTs span nearly two 347 
decades and, unless specific consent was obtained at the time of the initial trial, obtaining 348 
follow up data might be impossible. 349 
Another option might be to use data from national registries and other published studies, 350 
including RCTs, across the world to conduct an individual patient data meta-analysis (IPD-351 
MA) (Riley et al., 2010). This method would increase power for the assessment of rare 352 
outcomes and, unlike meta-analyses of aggregated data, allow researchers to adjust for 353 




Perinatal outcomes in singleton live births associated with the transfer of fresh blastocysts are 356 
not different from those of singleton live births after cleavage-stage embryo transfer. However, 357 
although our findings are reassuring for women having the transfer of fresh blastocyst-stage 358 
embryos, our study is based on observational data with several limitations. Further robust 359 
evidence is needed before drawing a definitive conclusion about perinatal safety of extended 360 
embryo culture.  361 
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